Voya Investment Management LLC I Teos Therapeutics, Inc. Transaction History

Voya Investment Management LLC

  • $79.9 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$9.89 - $13.64 $18,514 - $25,534
-1,872 Reduced 8.44%
20,312 $277,000
Q3 2023

Nov 14, 2023
BUY
$10.95 - $14.6 $4,478 - $5,971
409 Added 1.88%
22,184 $242,000
Q2 2023

Aug 14, 2023
BUY
$12.93 - $18.05 $281,550 - $393,038
21,775 New
21,775 $288,000
Q2 2022

Aug 15, 2022
SELL
$16.57 - $35.1 $132,278 - $280,203
-7,983 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$26.23 - $47.86 $8,078 - $14,740
-308 Reduced 3.71%
7,983 $372,000
Q1 2021

May 17, 2021
BUY
$30.86 - $44.2 $255,860 - $366,462
8,291 New
8,291 $283,000

Others Institutions Holding ITOS

# of Institutions
165
Shares Held
36.6M
Call Options Held
1.95M
Put Options Held
374K
View Full List

About iTeos Therapeutics, Inc.

ITOS Quotes by TradingView
  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $293M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email